National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

glycosylated recombinant human interleukin-7
A glycosylated recombinant protein which is chemically identical to or similar to endogenous human interleukin-7 (IL-7) with hematopoietic and immunopotentiating activities. Naturally produced by bone marrow, thymic stromal, and spleen cells, the cytokine interleukin-7 is a hematopoietic growth factor for progenitor B cells and T cells, stimulating proliferation and differentiation of mature T-cells and natural killer (NK) cells. As with glycosylated endogenous proteins, glycosylation of recombinant proteins may fundamentally affect their biological activity, function, clearance from circulation, and antigenicity; glycosylation of recombinant proteins that are chemically identical to similar to endogenous proteins may render protein structures and biological activities that are more similar to those of glycosylated endogenous proteins. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:CYT107
Abbreviation:glycosylated rhIL-7



Previous:glutamine, glutathione disulfide NOV-002, glycine, glycopeptide antibiotic, glycosylated recombinant human G-CSF AVI-014
Next:GM-CSF-encoding oncolytic herpes simplex virus, GM-K562 cell vaccine, GM.CD40L cell vaccine, GM2-KLH vaccine, gold sodium thiomalate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov